Menu Back toPMDA Town Hall

DIA 2021 Global Annual Meeting

PMDA Town Hall

Session Chair(s)

Nobumasa  Nakashima, PhD

Nobumasa Nakashima, PhD

  • Associate Executive Director for International Programs
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan
PMDA’s activity is based on "4Fs" (Patient First, Access First, Safety First, Asia First) as priority policy, which Dr. Fujiwara, chief executive, has set up. In this session, PMDA will introduce its efforts around "4Fs" including those for COVID19.
Learning Objective : Describe the latest information regarding PMDA and Japanese regulations; Discuss how to foster dialogue between participants and senior PMDA officials concerning drug/device regulatory challenges.


Fumi  Yamamoto


Fumi Yamamoto

  • Councilor for Pharmaceutical Affairs, Minister’s Secretariat
  • Ministry of Health, Labour and Welfare (MHLW), Japan
Yasuhiro  Fujiwara, MD, PhD


Yasuhiro Fujiwara, MD, PhD

  • Chief Executive
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Kenichi  Tamiya, MSc, RPh


Kenichi Tamiya, MSc, RPh

  • Associate Executive Director
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan